Jöns Jacob Berzelius — the Swedish chemist who introduced the modern symbolic notation for elements and compounds — coined the term catalysis in 1836, from Greek roots meaning loosening down: he had noticed that certain substances accelerated reactions without themselves being consumed. In 1909, Fritz Haber demonstrated catalytic ammonia synthesis (N₂ + 3H₂ ⇌ 2NH₃) over an osmium catalyst (Nobel 1918), and Carl Bosch (Nobel 1931) industrialized the process at BASF using a cheaper iron catalyst — today the Haber-Bosch process consumes about 1–2% of global energy, produces ~150 million tonnes of ammonia per year, and supports the food supply for an estimated half of humanity through synthetic nitrogen fertilizer. No human technology depends more deeply on catalysis, and every cell of every organism alive runs on its own kind: enzymes, biological catalysts that are extraordinarily selective, fast, and specific.
A catalyst increases the rate of a chemical reaction without itself being consumed and without changing the equilibrium; mechanistically, it provides an alternative reaction pathway with a lower activation energy, and the Arrhenius equation k = A·exp(−Eₐ/RT) is exponentially sensitive to Eₐ, so even modest reductions produce large rate increases — but catalysts only change the speed of approaching equilibrium, not ΔG° or K. Homogeneous catalysts sit in the same phase as the reactants (acid catalysis of ester hydrolysis, transition-metal complexes catalyzing alkene polymerization in Ziegler-Natta, enzymatic reactions) and offer well-defined active sites and mechanistic tractability at the cost of hard separation from products, while heterogeneous catalysts sit in a different phase (the iron catalyst for ammonia synthesis, platinum in automotive converters, zeolites for petroleum cracking) and offer easy product separation and robustness at the cost of complex active sites. Enzymes are biological catalysts — proteins (and a few RNAs, ribozymes) — with active sites complementary to their substrate, narrow substrate specificity, enormous rate enhancements (10⁶–10²⁰), and regulation through allosteric control, post-translational modification, and feedback inhibition; Michaelis-Menten kinetics (1913) gives v = V_max·[S] / (K_M + [S]), and coenzymes (NAD⁺, FAD, coenzyme A — vitamins are coenzyme precursors) extend their chemical capabilities. Catalyst design balances activity (high turnover frequency), stability under reaction conditions, cheapness (precious metals are great but expensive), and especially selectivity — a catalyst with 99% selectivity for the desired product at modest rate is far more valuable than one that runs faster but produces side products. Catalyst poisons bind irreversibly to active sites and shut down activity (lead poisoned platinum converters and is why leaded gasoline was phased out, sulfur poisons many transition-metal catalysts), and modern surface science (STM, ambient-pressure XPS, single-atom catalysis) is increasingly able to identify active species at atomic resolution.
About 85% of all industrial chemical processes use catalysts — ammonia synthesis (food supply), petroleum refining (gasoline, jet fuel), petrochemicals (plastics, fibers), pharmaceuticals, automotive converters, polymerization, and increasingly electrocatalysis for energy applications. Asymmetric (enantioselective) catalysis — producing one mirror-image isomer rather than both — is critical for pharmaceuticals (where one enantiomer is the active drug and the other can be inactive or harmful, as with thalidomide), and Nobel Prizes in 2001, 2010, and 2021 all recognized catalysis advances. Single-atom catalysis (anchoring individual metal atoms on supports) is the current frontier for atom efficiency, and electrocatalysis (water splitting, CO₂ reduction, fuel cells) is the central technology of green hydrogen and power-to-X. Computational catalyst design (DFT augmented by machine learning) screens thousands of candidate materials before any wet-lab work, and engineered enzymes are produced at scale for detergents, biofuels, and pharmaceuticals. The phenomenon Berzelius named in 1836 is, in retrospect, the technology that made modern chemical industry — and modern agriculture — possible.